These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 13440745)

  • 1. [Cardiopulmonary hemodynamic behavior after intravenous administration of lanatoside C in mitral valve disease].
    BRUSCA A; ACTIS DATO A; LEVI V; TARQUINI A
    Minerva Med; 1957 Apr; 48(32):1417-23. PubMed ID: 13440745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic study of the effects of acetyldigitoxin in mitral heart patients].
    ANDREUZZI P; MAGGI GC
    Cuore Circ; 1958 Oct; 42(5):280-96. PubMed ID: 13619306
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the renal circulation and renal function in mitral valvular disease. IV. The effect of a single intravenous injection of lanatoside C.
    BUCHT H; EK J; VARNAUSKAS E; WERKO L
    Cardiologia (Basel); 1956; 29(5):305-20. PubMed ID: 13383483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies of a cardiotonic glycoside: acetyldigitoxin].
    BAGUENA CANDELA R; TORMO ALFONSO V
    Med Esp; 1958 Dec; 40(237):483-503. PubMed ID: 13632284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of lanatoside C on the pulmonary circulation in mitral valve defect].
    WERKO L; ELIASCH H; THOMASSON B; VARNAUSKAS E
    Nord Med; 1955 Apr; 53(14):568-71. PubMed ID: 14384034
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of lanatoside C in current heart therapy].
    KRACKE R
    Med Klin; 1958 Apr; 53(16):711-4. PubMed ID: 13551810
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intravenous lanatoside-C upon cardiodynamics in patients with mitral stenosis and regular sinus rhythm.
    GREENE MA; GORDON A; BOLTAX AJ
    Am Heart J; 1961 May; 61():622-33. PubMed ID: 13708300
    [No Abstract]   [Full Text] [Related]  

  • 8. The circulatory and ventilatory changes in chronic pulmonary disease as affected by lanatoside C.
    GRAY FD; WILLIAMS MH; GRAY FG
    Am Heart J; 1952 Oct; 44(4):517-30. PubMed ID: 12976336
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic cardiac insufficiency; prolonged oral lanatoside C therapy.
    ABRAHAM A
    Med Times; 1958 Sep; 86(9):1080-2. PubMed ID: 13577199
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of lanatoside C in patients with sinusal rhythm].
    CORSI V
    Cuore Circ; 1951 Dec; 35(6):358-69. PubMed ID: 14905903
    [No Abstract]   [Full Text] [Related]  

  • 11. Intramuscular desacetyl lanatoside C: a safe and practical method of parenteral digitalization.
    ENSELBERG CD; DAVOODZADEH N; RIAHI H
    N Y State J Med; 1958 Dec; 58(24):4011-8. PubMed ID: 13613514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lanatoside C therapy of cardiac insufficiency highly sensitive to glycosides].
    BARFOD H
    Munch Med Wochenschr; 1959 Apr; 101(16):716-7. PubMed ID: 13656996
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of preoperative and postoperative hemodynamic parameters in replacement or reconstruction of the mitral valve in ischemic dilated cardiomyopathy].
    Mijatov M; Jonjev Z; Konstantinović Z; Golubović M; Radovanović N
    Med Pregl; 2000; 53(1-2):68-73. PubMed ID: 10953555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
    Gandham R; Syamasundar A; Ravulapalli H; Karthekeyan RB; Vakamudi M; Kodalli R; Nandipati S
    Ann Card Anaesth; 2013; 16(1):11-5. PubMed ID: 23287080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral valve repair.
    Winters M; Obriot P
    AORN J; 2007 Jan; 85(1):152-66; quiz 167-70. PubMed ID: 17223405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
    Wang H; Gong M; Zhou B; Dai A
    Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical indications in mitral valve stenosis, combined mitral valve defect or mitral valve insufficiency. Long-term prognosis of operated or drug-treated patients].
    Schwarz F; Böttger J; Olschewski M; Scheurlen H; Manthey J; Storch HH; Saggau W; Kübler W
    Herz; 1986 Apr; 11(2):74-87. PubMed ID: 3699676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of mitral valve replacement in children: a competing-risks analysis.
    Kojori F; Chen R; Caldarone CA; Merklinger SL; Azakie A; Williams WG; Van Arsdell GS; Coles J; McCrindle BW
    J Thorac Cardiovasc Surg; 2004 Nov; 128(5):703-9. PubMed ID: 15514597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.